Tobacco Use Disorder: Clinical Trials

95 trials for Tobacco Use Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

69 completed, 9 recruiting, 7 terminated, 4 unknown. 95 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 495Completed 69, Recruiting 9, Terminated 7, Unknown 4, Withdrawn 4, Active not recruiting 1, Not yet recruiting 1

Follow Tobacco Use Disorder: new trials by email Literature Review of Tobacco Use Disorder trials Research Report on Tobacco Use Disorder

Trials (filtered) newest first · largest first

All 95 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge, Cessation-Phase Combination Nicotine Replacement Therapy (NRT) - Veterans, Tobacco Use Disorder
Phase 4RecruitingVA Office of Research and Development4002026-08-172026-08-31
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Varenicline, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham - Nicotine Dependence, Transcranial Magnetic Stimulation
Phase 4RecruitingMassachusetts General Hospital302026-07-022026-09-15
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4Active not recruitingJohns Hopkins University302025-12-102026-07-06
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
Nicotine Replacement Therapy (NRT), Wellness Coaching - Tobacco Cessation, Tobacco Abstinence
Phase 4RecruitingUniversity of California, San Francisco1502025-11-142025-11-21
tDCS Plus Varenicline for Smoking Cessation
Active Transcranial Direct Current Stimulation (tDCS), Varenicline 1mg BID, Sham Transcranial Direct Current Stimulation (tDCS) - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health1602025-03-102025-08-12
E-cigarette Cessation in Adults Who Co-use Cannabis
Varenicline Pill, Contingency management, Counseling - Nicotine Dependence, Tobacco Use Disorder
Phase 4RecruitingMedical University of South Carolina1052025-02-192026-06-12
Beta-Adrenergic Modulation of Drug Cue Reactivity
Propranolol, Nicotine Patch, Placebo Propranolol - Tobacco Use Disorder, Nicotine Dependence
Phase 4RecruitingUniversity of Oklahoma802024-11-262026-04-28
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4CompletedJohns Hopkins University102024-10-302026-02-02
Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial
Brainsway H4 deep Repetitive Transcranial Magnetic Stimulation (rTMS) coil, Nicotine replacement - Tobacco Use Disorder, Psychiatric Disorder
Phase 4RecruitingCentre for Addiction and Mental Health402024-09-012025-12-11
Emergency Department Management of Tobacco Use Disorder
Nicotine Replacement Therapy Agent, West Virginia Quit Line - Tobacco Use Disorder, Tobacco Use Cessation
Phase 4WithdrawnWest Virginia University2024-08-012025-01-02
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4CompletedJohns Hopkins University52024-04-302025-09-10
Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
Brainsway H4 deep rTMS coil and Brainsway stimulator system - Smoking
Phase 4RecruitingCentre for Addiction and Mental Health402024-03-302026-03-27
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
Bupropion, Nicotine replacement therapy (Nicotine patches) - Tobacco Smoking, Tobacco Withdrawal
Phase 4UnknownNational Institute of Respiratory Diseases, Mexico1342024-01-152024-02-23
Cytisine for Smoking Cessation
Cytisine, Placebo - Tobacco Use Disorder, Alcohol Use Disorder
Phase 4CompletedCentre for Addiction and Mental Health202023-02-082026-02-27
Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction
n-acetylcysteine, Motivational Enhancement Therapy - Nicotine Dependence, Nicotine Addiction
Phase 4CompletedUniversitas Indonesia902023-01-012024-10-08
Smoking Cessation and Menstrual Cycle Phase
Timing of nicotine replacement therapy start date, Nicotine Replacement Therapy Agent - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health12002022-11-302026-03-19
Varenicline for Nicotine Vaping Cessation in Adolescents
Double Blind Varenicline, Double Blind Placebo, QuitVaping - Vaping, Nicotine Dependence
Phase 4CompletedMassachusetts General Hospital2612022-06-222025-04-27
Methadone-Maintained Smokers Switching to E-Cigarettes
Electronic Cigarette, Nicotine Lozenge - Nicotine Dependence, Electronic Cigarette Use
Phase 4CompletedButler Hospital1832022-03-312026-08-20
Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy
Cytisine, Nicotine Replacement Therapy (NRT) - Nicotine Addiction
Phase 4CompletedLoma Linda University13072022-01-272024-09-19

Showing 20 of 95. Sign in to see all of them.

Narrower conditions

Smoking Cessation (44)  ·  Smoking (21)  ·  Vaping (9)  ·  Schizophrenia (8)  ·  Tobacco Use Cessation (7)  ·  Cigarette Smoking (6)  ·  Substance-Related Disorders (5)  ·  Tobacco Smoking (5)  ·  Psychotic Disorders (4)  ·  Marijuana Abuse (3)  ·  Mental Disorders (3)  ·  Substance Withdrawal Syndrome (3)  ·  Alcoholism (2)  ·  Carcinoma, Hepatocellular (2)

Broader conditions

Chemically-Induced Disorders (95)  ·  Mental Disorders (92)  ·  Substance-Related Disorders (90)  ·  Behavior (71)  ·  Health Behavior (51)  ·  Smoking (18)  ·  Tobacco Use (11)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (8)  ·  Tobacco Smoking (6)  ·  Mood Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Adenocarcinoma (2)  ·  Alcohol-Related Disorders (2)  ·  Bronchial Neoplasms (2)  ·  Carcinoma (2)

Interventions

Tobacco Use Cessation Devices (31)  ·  Varenicline (25)  ·  Bupropion (18)  ·  Nicotine (10)  ·  Nicotine Chewing Gum (10)  ·  Nicotine Replacement Therapy (10)  ·  Counseling (5)  ·  Behavior Therapy (3)  ·  Community Health Workers (3)  ·  Acetylcysteine (2)  ·  BID protein, human (2)  ·  Electronic Nicotine Delivery Systems (2)  ·  Motivational Interviewing (2)  ·  Sugars (2)  ·  Transcranial Magnetic Stimulation (2)

Sponsors

University of Wisconsin, Madison (13)  ·  Centre for Addiction and Mental Health (9)  ·  Massachusetts General Hospital (5)  ·  University of Pennsylvania (5)  ·  Johns Hopkins University (4)  ·  National Institute on Drug Abuse (NIDA) (4)  ·  University of California, San Francisco (3)  ·  Albert Einstein College of Medicine (2)  ·  Medical University of South Carolina (2)  ·  University of California, San Diego (2)  ·  VA Office of Research and Development (2)  ·  Yale University (2)  ·  American University of Beirut Medical Center (1)  ·  Arizona State University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (71)  ·  Canada (9)  ·  France (2)  ·  Austria (1)  ·  China (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Lebanon (1)  ·  Mexico (1)  ·  Mongolia (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Timothy B Baker, PhD (4)  ·  Alejandra Ellison-Barnes, MD (2)  ·  Eden Evins, MD (2)  ·  Laurie A Zawertailo, PhD (2)  ·  Laurie Zawertailo, PhD (2)  ·  Megan E Piper, PhD (2)  ·  Peter Selby, MD, MHSc (2)  ·  Randi Schuster, PhD (2)  ·  A Eden Evins, MD, MPH (1)  ·  Alasdair Barr, Ph.D (1)  ·  Amy J Arouni, MD (1)  ·  Andrea H. Weinberger, Ph.D. (1)  ·  Andrew Strasser, PhD (1)  ·  Anna Lembke, MD (1)  ·  Barbara W Kamholz, Ph.D. (1)

Results publications

PMID 37230961, PMID 37335995, PMID 37142273, PMID 39868569, PMID 11282701, PMID 17632223, PMID 17763111, PMID 18418793, PMID 18838243, PMID 18842256, PMID 19251401, PMID 19373517, PMID 19733449, PMID 20008701, PMID 20236788, PMID 20308641, PMID 20395358, PMID 21266057, PMID 21382516, PMID 21535998, PMID 21775497, PMID 21885891, PMID 21999719, PMID 22172440, PMID 22241828, PMID 22496918, PMID 22608375, PMID 22695488, PMID 22853197, PMID 23422399, PMID 23733379, PMID 24893290, PMID 24938369, PMID 25705872, PMID 25867447, PMID 26336372, PMID 26429100, PMID 26813210, PMID 26953688, PMID 27117285, PMID 27647058, PMID 27839954, PMID 27890648, PMID 27923864, PMID 28756042, PMID 29251951, PMID 29696311, PMID 30280019, PMID 30874290, PMID 30920255

NIH funding

P50CA143188 (3), P50DA019706 (3), R01DA052583 (2), R01HL109031 (2), R37CA237245 (2), K23DA025736 (1), K24DA030301 (1), P01CA180945 (1), P50CA084724 (1), R01CA091912 (1), R01CA165080 (1), R01CA184211 (1), R01DA004174 (1), R01DA008075 (1), R01DA012289 (1)